Atazanavir Sulfate

규격

229975-97-7CAS 번호

620-495-2EC 번호

methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acidIUPAC 명칭

C38H54N6O11S화학식

802.9 g/mol분자량

Atazanavir sulfate; 229975-97-7; Atazanavir sulphate; BMS-232632-05; Atazor; Atazanavir so4; Atazanaviri sulfas; 4MT4VIE29P; NSC-742546; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); DTXSID401017206; EVOTAZ COMPONENT ATAZANAVIR SULFATE; 232632, BMS; CHEBI:31243; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); RefChem:54331; DTXCID801475397; CGP73547; CGP75176; CGP75355; BMS232632; CGP-75176; BMS23263205; BMS 232632 05; 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester; CGP-75136; dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-(4-(2-pyridyl)benzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate; Reyataz; Atazanavir (sulfate); Atazanavir sulfate [USAN]; MFCD08067748; methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate; Reyataz (TN); Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) (salt); methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acid; SMR002544693; Atazanavir Bisulfate Salt; BMS-232632 sulfate; UNII-4MT4VIE29P; C38H54N6O11S; 229975-97-7 (sulfate); Atazanavir sulfate RS; Atazanavir sulfate CRS; Atazanavir (as sulfate); MLS003915641; MLS006010199; SCHEMBL341700; orb1225587; orb1310937; ATAZANAVIR SO4 [VANDF]; ATAZANAVIR SULFATE [MI]; Atazanavir sulfate (JAN/USAN); ATAZANAVIR SULFATE [JAN]; CHEMBL1200678; SCHEMBL29362158; Atazanavir (sulfate) (Standard); DQSGVVGOPRWTKI-QVFAWCHISA-N; GLXC-06688; HY-17367AR; ATAZANAVIR SULFATE [MART.]; ATAZANAVIR SULFATE [USP-RS]; ATAZANAVIR SULFATE [WHO-DD]; ATAZANAVIR SULFATE [WHO-IP]; EX-A4010; HY-17367A; Atazanavir Sulfate [USP MONOGRAPH]; AKOS016000176; ATAZANAVIR SULPHATE [EMA EPAR]; CCG-270493; CS-1890; FA29047; NSC 742546; ATAZANAVIR SULFATE [ORANGE BOOK]; ATAZANAVIR SULFATE [EP MONOGRAPH]; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt); AS-14954; ATAZANAVIRI SULFAS [WHO-IP LATIN]; DA-61286; A3411; A4040; SW220258-1; D01276; SBI-0654095.0001; Q27114238; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1); methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate sulfate; Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate sulfate; methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid; Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]am ino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate; Sulfuric acid--methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (1/1)동의어